## **Core Concept**
Aminoglycosides are a class of antibiotics that work by inhibiting bacterial protein synthesis. They are often used to treat severe bacterial infections. However, their effectiveness can be compromised by bacterial enzymes that modify and inactivate these drugs.

## **Why the Correct Answer is Right**
Amikacin is known for its resistance to most aminoglycoside-modifying enzymes. These enzymes, produced by bacteria, can phosphorylate, adenylate, or acetylate aminoglycosides, rendering them ineffective. Amikacin's chemical structure makes it less susceptible to these modifications, thereby maintaining its antibacterial activity against a broader range of bacteria that produce these inactivating enzymes.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Gentamicin is susceptible to inactivation by several bacterial enzymes, which can limit its effectiveness against certain strains of bacteria.
* **Option B:** Tobramycin is also susceptible to aminoglycoside-modifying enzymes, though it may have a slightly different spectrum of activity compared to gentamicin.
* **Option D:** Netilmicin has a similar resistance profile to some inactivating enzymes but is not as broadly resistant as amikacin.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that amikacin is often used in cases where resistance to other aminoglycosides is a concern. However, its use must be balanced with potential nephrotoxicity and ototoxicity, which are class effects of aminoglycosides.

## **Correct Answer:** C. Amikacin.